secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0000937556-25-000029
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo Q4 revenue $601M (+9%); Non-GAAP EPS $1.80 (+44%); FY2025 guide sees healthcare growth 8-11%
--------------------------------------------------------------------------------

- Q4 revenue $601M (+9% YoY); Healthcare $368M (+8%), Non-healthcare $232M (+11%).
- GAAP net loss per share ($6.52) due to Sound United impairment; Non-GAAP diluted EPS $1.80 (+44%).
- Full-year 2024 healthcare revenue $1,395M (+9%); Non-healthcare revenue $699M (-10%).
- FY2025 guidance: Healthcare revenue $1.50B-$1.53B (8-11% constant currency), Non-GAAP EPS $5.10-$5.40.
- New CEO Katie Szyman cites strong healthcare momentum and record customer contracts in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755625000029/0000937556-25-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755625000029/masi-20250225.htm
  HTML page:      https://secwatch.observer/filing/0000937556-25-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer